HIGHLIGHTS
- What: The aims of this report are to emphasize the potential clinical significance of BARD1 mutation in breast cancer and to pursue a more tailored medical management to this mutation and genetic testing in family members to assess future risk of malignancy.
- Who: Joseph McGrath and colleagues from the DrKiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Davie, USA, . General Surgery have published the Article: Received 04/05/2024 Review began 06/05/2024 Review ended 07/30/2024 Published 08/05/2024, in the Journal: (JOURNAL) of August/05,/2024
-

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.